Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Treatment of aneurysmal bone cysts using endoscopic curettage

  • 1,
  • 1, 5Email author,
  • 2,
  • 1,
  • 3,
  • 1,
  • 1,
  • 1,
  • 3,
  • 1,
  • 1,
  • 1,
  • 1,
  • 4 and
  • 1
BMC Musculoskeletal Disorders201819:268

https://doi.org/10.1186/s12891-018-2176-6

  • Received: 28 January 2018
  • Accepted: 10 July 2018
  • Published:
Open Peer Review reports

Abstract

Background

Although aneurysmal bone cysts (ABCs) are benign tumours, they have the potential to be locally aggressive. Various treatment approaches, such as en bloc resection, open curettage, radiotherapy, sclerotherapy, and embolization have been proposed, but the most appropriate treatment should be selected after considering the risk of tumour recurrence and treatment complications. Endoscopic curettage (ESC) may be a less invasive alternative to open curettage for ABC treatment. We aimed to describe the use of ESC for the treatment of ABCs and to report our clinical outcomes, including the incidence rate of recurrence, radiological appearance at final follow-up, time to solid union, complications, and postoperative function.

Methods

Between 1998 and 2015, 30 patients (18 men and 12 women; mean age, 17.4 years) underwent ESC for the treatment of primary ABCs at our hospital (mean postoperative follow-up, 55 months). ESC was performed under arthroscopic guidance for direct visualization, and curettage extended until normal bone was observed in the medullary cavity. To investigate bone healing after ESC, we evaluated the consolidation of cysts at the final evaluation (based on the modified Neer classification) and time to solid union after surgery, which was defined as sufficient cortical bone thickness to prevent fracture and allow physical activities.

Results

Recurrence was identified in 3 cases (10%). Curative outcomes were obtained after repeated ESC or open curettage. A log-rank analysis indicated that age < 10 years (p = 0.004) and contact of the tumour with the physis (p = 0.01) increased the risk of tumour recurrence. Residual tumours were identified in 9 cases (30%); these lesions remained inactive over the extended follow-up period. The average time to solid union after endoscopic curettage was 3.2 months. Transient radial nerve palsy was identified in 1 case. Good postoperative functional recovery occurred in all cases.

Conclusions

ESC is a minimally invasive technique for the treatment of ABCs, and the tumour recurrence rate is comparable to that of other standard procedures. However, the application of this method should be carefully considered, especially for patients < 10 years and when the tumour comes in contact with the physis.

Keywords

  • Endoscopy
  • Endoscopic curettage
  • Bone tumour
  • Aneurysmal bone cyst

Background

Aneurysmal bone cysts (ABC) are expandable cavities that form within bone and are filled with blood and lined with proliferative fibroblasts, giant cells, and trabecular bone [1]. An ABC generally arises either as a primary neoplasm derived from translocation [2] or as a secondary lesion adjacent to osteoblastoma, giant cell tumours, or other types of tumours [3]. The goal of treatment is to stop the progression of the lesion, relieve pain, and prevent pathological fracture of the bone [4]. The following various treatment approaches have been proposed to meet these therapeutic goals: en bloc resection; curettage with or without burring or adjuvant therapy [5, 6]; radiotherapy [7]; curopsy, which is a novel biopsy technique introduced by Reddy et al. [8]; sclerotherapy [9]; and embolization [10]. Selection of the most appropriate treatment for any case depends on the risk of tumour recurrence and comorbidity associated with the treatment. In this study, we proposed the use of endoscopic curettage (ESC) as minimally invasive surgery for the treatment of ABCs and reviewed the surgical and clinical outcomes of this treatment approach.

Methods

Patient selection for ESC and relevant characteristics of the study group

From 1998 to 2014, 37 primary ABCs (37 patients) were diagnosed at our hospital, and histopathological confirmation was performed by our division of pathology. Among these, ESC was not performed for 7 cases after the initial clinical examination because of uncertainty regarding the diagnosis on imaging; therefore, open biopsy was indicated for exclusion of malignancy (n = 5) or the risk of pathological fracture after ESC (n = 2). The remaining 30 cases (18 men and 12 women; median age, 17.4 years; range, 5.8–40.0 years) were treated with ESC. For cases of pathological fracture before treatment, we waited 4–5 weeks until the cavities were closed because cortical continuity was necessary for irrigation of the cyst during surgery (Fig. 1). ABCs were located in tubular bones in 19 cases (12 humeri, 4 tibias, 2 femora, and 1 s metatarsal bone), in flat bones in 7 cases (3 ilia, 3 ischia, and 1 pubis), in short bones in 3 cases (2 calcanei and 1 os naviculare), and in a sesamoid bone in 1 case (patella). The mean maximum cyst diameter was 66.8 (standard deviation [SD], 32.9) mm. Patients were followed-up until bone healing; however, when the cyst did not consolidate over time, the patients were monitored for at least 2 years postoperatively. The mean overall follow-up period was 55.0 (SD, 34.3) months. Additional information regarding patient characteristics is available (Additional file 1).
Fig. 1
Fig. 1

Flow diagram of patient selection for ESC treatment for ABC. For cases of atypical radiological appearance of an ABC, we proceeded with open biopsy to exclude the presence of a giant cell tumor, telangiectatic osteosarcoma, or other malignant bone tumor with a cyst. Moreover, to prevent femoral fracture after ESC, we proceeded with open curettage and artificial bone grafting, with or without internal fixation, for cases of large cystic lesions (lesion/cortex ratio > 2/3) located in the femoral trochanter (details provided in the Discussion). For ABCs at all other locations where a pathological fracture was visible at the time of the initial diagnosis, ESC was performed after bone union. Ultimately, 30 patients underwent ESC without an artificial bone graft. *1. In 5 cases, curettage with βTCP (OSferion; Olympus Co., Tokyo, Japan) was performed after intraoperative open biopsy for confirmation of ABC. This was because giant cell tumors were first suspected in 4 cases, and a cystic lesion that arose in an unusual location (clavicle) was not regarded as ABC according to the diagnosis indicated by preoperative imaging. *2: An ABC with a large cystic lesion (lesion/cortex ratio > 2/3) located in the femoral trochanter was regarded as a contraindication for ESC

Surgical procedure

Tumour location was determined using an image intensifier and marked on the skin. The position and number (2–4) of portals for the arthroscope were based on the location and size of the tumour and created via a 1-cm-long skin incision with blunt dissection. Then, the cortical bone was penetrated using Kirschner wire. The small aperture of the cortical bone was subsequently enlarged up to 7–8 mm using step-up cannulated drills (Fig. 2a). Then, an arthroscope (straight or angled) was inserted and the tumour was curetted using angled curettes, rongeurs, or an electric shaver (Fig. 2b-d). The insertion holes for the arthroscope and surgical instruments were interchanged to achieve complete curettage and provide an adequate visual field through the arthroscope. The cystic lesion was thoroughly removed until normal bone was observed in the medullary cavity (Fig. 3a-c).
Fig. 2
Fig. 2

Surgical procedure and devices. a Penetration of the bone with a Kirschner wire. bStep-up cannulation up to 7–8 mm. c The device used for curettage, including angled curettes and rongeurs. d Curettage performed using angled curettes and an electric shaver

Fig. 3
Fig. 3

Endoscopic images. a The cavity of an ABC covered with blood clots and a synovial membrane. b The removal of neoplastic tissue using curettes. c Curettage was extended until normal bone was visible in the medullary cavity

Postoperatively, patients who were treated for an ABC of the lower limb were maintained until partial weight-bearing up to 50% body weight for 1 month with crutches. This was increased to two-thirds of body weight until radiological confirmation of bone healing, which typically occurred at 3 months postoperatively. Patients with an ABC on the upper limb or non-weight-bearing bone had no restrictions in activities except for contact sports until bone healing.

Postoperative evaluation

The rate of postoperative complications and functional recovery, measured in terms of the Musculoskeletal Tumor Society Score (MSTS), was evaluated after treatment [11]. Regarding bone healing time after ESC, solid union was determined based on the criteria of Hou et al. [12], which was defined as sufficient regression of the cyst to obtain a cortical wall thick enough to prevent further fracture and allow unrestricted physical activity. Cyst consolidation at the final evaluation was classified based on the modified Neer classification [12, 13] (Table 1).
Table 1

Modified Neer classification

Classification

Description

Details

A

Healed

Cyst filled with new bone with small radiolucent area (< 1 cm)

B

Healed with a defect

Radiolucent area (< 50% diameter) with enough cortical thickness

C

Persistent cyst

Radiolucent area (50% diameter) with thin cortical rim

D

Recurrent cyst

Cyst reappearing in the obliterated area or in the increased residual radiolucent area

Statistical analysis

Risk factors for recurrence were evaluated using the Kaplan-Meier analysis and the log-rank test. Anonymised radiographical images were evaluated by an orthopaedic surgeon (H.A.) and a radiologist (T.G.) for double-blind confirmation of the classification. Then, the kappa value was calculated to evaluate inter-observer errors regarding the morphological appearance of the bone. For statistical analysis of the categorical data, a chi-squared analysis was used. A p-value < 0.05 was considered significant for all analyses. Measured variables were presented as mean and standard deviation or median with range, as appropriate, for the data distribution. All statistical analyses were conducted using SPSS version 24 (IBM, Chicago, IL).

Results

Among the 30 patients included in our study group, ESC was performed using an average of 2.3 portals (4 portals in 3 cases; 3 portals in 4 cases; and 2 portals in 23 cases). The number of portals depended on the size of the lesion. The median operative time was 107.8 (range, 47.0–197.0 min), with a median intraoperative bleeding volume of 34.2 mL (range, near 0–354 mL), which was estimated from the total amount of irrigation fluid. Images for a typical case are shown in Fig. 4.
Fig. 4
Fig. 4

Typical case of a suspected ABC treated with ESC. Magnetic resonance (MR) images of a 16-year-old boy who presented with bruising of his hip sustained during contact sports participation: (a) axial T2; (b) coronal T2-weighted; and (c) coronal T1-weighted enhanced with gadolinium (Gd). The plain radiograph is shown in (d). The preoperative computed tomography (CT) image (e) shows the bone lesion with cortical thinning extending from the iliac wing to the periacetabular area. Plain radiographs after surgery (f). CT image at 6 months after ESC (g) shows remodeling of the cystic lesion by cancellous bone. At 6 years after ESC (h), the pelvic bone was fully remodeled despite a residual cyst and without any symptoms (class B) (i)

Recurrence rate after ESC

During the follow-up period, tumour recurrence was identified in 3 cases (3/30; 10%), with a curative outcome achieved in all 3 cases with repeated ESC or open curettage. The log-rank analysis (Table 2) showed that age < 10 years (p = 0.004) and tumour involvement of the physis (p = 0.01) were associated with tumour recurrence.
Table 2

Variables associated with ABC tumour recurrence

Variable

Number of cases (N = 30)

Recurrence

P-value

Age, y

  

0.004

  < 10

8

3

 

10

22

0

 

Sex

  

0.776

 Male

18

2

 

 Female

12

1

 

Location

  

0.949a

 Tubular bone

19

2

 

 Flat bone

7

1

 

 Short bone

3

0

 

 Sesamoid bone

1

0

 

Pathologic fracture

  

0.220

 Yes

4

1

 

 No

26

3

 

Contact with physis

  

0.010

 Yes

10

3

 

 No

20

0

 

Maximum length of tumour

  

0.966

  < 50 mm

11

1

 

50 mm

19

2

 

aPooled over strata comparison

Healing after ESC

The average time to solid union after ESC was 3.2 (SD, 1.7) months. The modified Neer classifications of the final status after ESC for all 30 cases were as follows: 21 cases with class A-B (healed cyst) and 9 cases with class C (persistent cyst) (assessed by H.A.). The kappa value of intra-observer reliability was substantial (0.76; p = 0.001; the differences of the 2 observers are provided in Additional file 1). Although tumour size was not significantly associated with the residual tumour, there was a predilection for cyst residue (class C) with large tumours (> 50 mm; p = 0.09; chi-squared analysis). For all class C cases, the cystic lesion did not increase during the follow-up period. These patients were carefully monitored at each follow-up visit. The diameter of the cyst remained stable in all cases over several years until the last follow-up.

Complications and function after ECS

Almost all patients recovered excellent function after ESC (MSTS = 30), with the exception of 1 patient who reported persisting pain due to a lumbar disc herniation. Tumour recurrence was identified in 3 cases, with 1 progressing to a postoperative fracture after the third recurrence. Transient radial nerve palsy was identified in 1 case. There were no cases of infection, intraoperative fracture, or deformity.

Discussion

In this study, we reported the surgical and clinical outcomes of a relatively large case series of patients with an ABC treated with ESC. Open curettage and reconstruction of the defect with a bone graft, as described by Jaffe et al. [14], remain the mainstay of modern treatment of ABCs [4], with the rate of tumour recurrence ranging between 40 and 90% [6]. Several procedures have been developed as options for the eradication of micro-residue tumours to improve local control and lower the rate of recurrence, including the use of high-speed burring or chemical treatment (such as the use of liquid nitrogen or polymethylmethacrylate) with or without thermal effects [1517]. However, the exudate of these agents from the surgical site may damage the surrounding soft tissues. Therefore, endoscopy-guided surgery was proposed as an alternative treatment. Endoscopy provides the advantage of accurately assessing tumour resection via direct examination of the bone marrow cavity for complete removal of the cyst (when possible). Direct visualization also avoids blind spots or excessive curettage, which may result in an intraoperative fracture or brittleness of the treated bone [18, 19]. Furthermore, because endoscopy can be performed via small port holes requiring only small incisions, the procedure is aesthetically superior and less invasive compared to open procedures. Despite the prolonged operation time due to the preparation of holes and careful piece-by-piece curettage to avoid excessive curettage or remaining tumour, ESC might be a good alternative for the treatment of benign bone tumours.

ESC can be applied to other types of tumours. Since the early 1990s, when minimally invasive approaches were preferred, we have performed ESC for the treatment of enchondromas, unicameral bone cysts, and chondroblastomas [2022]. Stricker introduced the extra-articular approach for the treatment of chondroblastoma arising in the epiphysis without violating the joint surface and recurrence [23]. Moreover, Errani, et al. reported their experience with the treatment of chondroblastoma arising in the vicinity of the knee joint and introduced ESC as an approach that allowed as much visualisation as possible of the residual tumour and avoided violating the joint surface [24].

ESC aims to achieve complete tumour resection and to facilitate new bone formation by direct stimulation of cysts. Recently, Reddy et al. [8] described curopsy, which is defined as percutaneous limited curettage at the time of biopsy, as a viable approach to resecting the membrane lining various quadrants of the cyst. They reported a tumour recurrence rate of 18.6% and time to bone healing of 9.6 weeks. Our results were comparable to these (10% recurrence rate after ESC). Similar to biopsy or curopsy, we postulated that ESC had a role in stimulating bone healing after penetration of small holes and was effective for removing tumour cells lining the cyst walls. In general, the healing process after biopsy of an ABC can be slow or rapid [25]. Slow healing after biopsy is a good indication for subsequent surgery to prevent further tumour progression or pathologic fracture. In contrast, rapid healing after biopsy is an indication to delay or postpone surgery to prevent unnecessary complications. Therefore, it is important to note that ABCs present with a broad spectrum of biological aggressiveness; therefore, ESC might fail in the case of aggressive lesions [26]. However, in our case series, we did not observe a rapid increase in osteolytic lesions after ESC; therefore, insistent curettage in the cavity by ESC is possibly important to achieve total removal of the resident tumour.

We excluded cases in which ESC might have lessened the strength of the bone during the postoperative period prior to bone healing. This decision was based on our prior experience during our early period of performing ESC, when we experienced 2 cases of postoperative fracture in patients in whom ESC was used for to treat a unicameral bone cyst. Currently, it is not possible to predict pathological fractures with benign bone tumours in paediatric patients [27]. Kaelin et al. [28] proposed the use of a cyst index (area of the cyst on a plain radiograph divided by the square of the diameter of the bone diaphysis at its tubular portion) to predict the risk of a pathological fracture, with a cutoff index of > 4 cysts identified for the humerus and a cutoff index of > 3.4 cysts for the femur being predictive of postoperative fractures. However, the positive predictive value of this index was limited and had a high false-positive return. Similar to the cyst index, Mirel’s score, which was originally introduced for the management of metastatic tumours and calculated as the sum of each value for the tumour position, pain, and the lesion/cortex ratio (the ratio of the maximum width of the lesion to the bone), is a practical method of predicting postoperative fractures that provides an indication for preemptive internal fixation [29]. We considered a lesion/cortex ratio of > 2/3 in the trochanteric region as a contraindication to ESC. Therefore, we chose to perform preemptive fixation in 2 cases with a cystic lesion of the trochanter due to concerns regarding severe functional restriction associated with pathological fractures of the trochanteric region of the femur and the patient anxiety associated with such an impairment. The validity of this strategy must be verified in further research.

Open growth plates [30] and the proximity of the bone cyst to the epiphysis [31] have been identified as risk factors for local recurrence. In our study, we identified age < 10 years and tumour involvement of the physis as risk factors for ABC recurrence after ESC. Based on our results, we suggest that indications for ESC should be considered carefully, and that a watch-and-see strategy is recommended for patients at high risk for local recurrence and low risk for pathological fractures.

There were some limitations to our study that need to be acknowledged. First, comparisons with other standard treatments are necessary to evaluate the outcomes of ESC treatment more precisely. Second, the sample size was limited; therefore, the power of our study was not strong. Third, all diagnoses were not confirmed by a genetic approach but histological appearance. In 2004, USP6 rearrangement and/or CDH11 rearrangement were reported in the majority of primary ABC cases (69%) [32]. Because secondary ABC did not involve these rearrangements, this translocation was considered to be a useful method of determining the differential diagnosis. Therefore, the accuracy of the diagnosis might have affected the results of this study. Finally, although all procedures were performed by a single surgeon, the effects of the learning curve for the ESC procedure need to be considered. In fact, 1 case of radial nerve palsy, probably resulting from blunt trauma in the area of the radial groove during the ESC procedure, was identified during the early technical development period. Therefore, preoperative planning is essential to avoid complications with ESC, including identification of the appropriate position of the holes to avoid the neurovascular structure and determination of the appropriate timing for intervention to lower the risk for pathological fractures.

Conclusion

To our knowledge, this is the first report of the outcomes of ESC for ABC treatment involving a relatively large case series. Nevertheless, a reliable comparison with other methods is difficult. We reported a lower recurrence rate than previous reports, and our patients recovered without long-lasting complications and achieved good functional recovery. However, further investigations are necessary to validate our methods.

Abbreviations

ABC: 

Aneurysmal bone cyst

ESC: 

Endoscopic curettage

SD: 

Standard deviation

Declarations

Acknowledgements

We thank the staff of the Division of Pathology of Nagoya City University Hospital for evaluating the histological specimens.

Availability of data and materials

All data are available in the Additional file.

Authors’ contributions

HA: Software use, validation, visualization, formal analysis, data curation, and original draft preparation. MkK: Conceptualization, main surgeon, methodology, and supervision. YWN: Surgeon and supervision. HG and HO: Surgeon and supervision. JM: Supervision and data curation. SY: Supervision and data curation. MN: Conceptualization, surgeon, and methodology. HM and MmK: Surgeon. SM: Reviewing and editing. KE and SS: Data curation. TG: Radiological assessment. TO: Reviewing and editing, project administration, and conceptualization. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This retrospective study received the approval of the local committee of Nagoya City University Hospital (no. 60–17-0071, approved on December 6, 2017) and was conducted in compliance with the guidelines of the Helsinki Declaration of 1975. Informed consent was obtained from the patients and their family members.

Consent for publication

Written informed consents were received from patients > 16 years or from the parent/legal guardian if the patient was < 16 years for publication of this report and accompanying images.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Orthopedic Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
(2)
Department of Joint Surgery for Rheumatic Diseases, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
(3)
Department of Rehabilitation Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
(4)
Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
(5)
Department of Orthopedic Surgery, Ogaki Municipal Hospital, 4-86 Minaminokawa-cho, Ogaki 503-8502, Japan

References

  1. Copley L, Dormans JP. Benign pediatric bone tumors. Evaluation and treatment. Pediatr Clin North Am. 1996;43:949–66.View ArticlePubMedGoogle Scholar
  2. Ye Y, Pringle LM, Lau AW, Riquelme DN, Wang H, Jiang T, Lev D, Welman A, Blobel GA, Oliveira AM, Chou MM. TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. Oncogene. 2010;29:3619–29. https://doi.org/10.1038/onc.2010.116. View ArticlePubMedPubMed CentralGoogle Scholar
  3. Martinez V, Sissons HA. Cancer. Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology 1988;61:2291–2304.Google Scholar
  4. Park HY, Yang SK, Sheppard WL, Hegde V, Zoller SD, Nelson SD, Federman N, Bernthal NM. Current management of aneurysmal bone cysts. Curr Rev Musculoskelet Med. 2016;9:435–44.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Cummings JE, Smith RA, Heck RK Jr. Argon beam coagulation as adjuvant treatment after curettage of aneurysmal bone cysts: a preliminary study. Clin Orthop Relat Res. 2010;468:231–7. https://doi.org/10.1007/s11999-009-0914-7.View ArticlePubMedGoogle Scholar
  6. Steffner RJ, Liao C, Stacy G, Atanda A, Attar S, Avedian R, Peabody TD. Factors associated with recurrence of primary aneurysmal bone cysts: is argon beam coagulation an effective adjuvant treatment? J Bone Joint Surg Am. 2011;93:e1221–9. https://doi.org/10.2106/JBJS.J.01067.View ArticlePubMedGoogle Scholar
  7. Feigenberg SJ, Marcus RB Jr, Zlotecki RA, Scarborough MT, Berrey BH, Enneking WF. Megavoltage radiotherapy for aneurysmal bone cysts. Int J Radiat Oncol Biol Phys. 2001;49:1243–7.View ArticlePubMedGoogle Scholar
  8. Reddy KI, Sinnaeve F, Gaston CL, Grimer RJ, Carter SR. Aneurysmal bone cysts: do simple treatments work? Clin Orthop Relat Res. 2014;472:1901–10. https://doi.org/10.1007/s11999-014-3513-1.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Varshney MK, Rastogi S, Khan SA, Trikha V. Is sclerotherapy better than intralesional excision for treating aneurysmal bone cysts? Clin Orthop Relat Res. 2010;468:1649–59. https://doi.org/10.1007/s11999-009-1144-8.View ArticlePubMedGoogle Scholar
  10. Rossi G, Mavrogenis AF, Facchini G, Bartalena T, Rimondi E, Renzulli M, Andreone A, Durante S, Angelini A, Errani C. How effective is embolization with N-2-butyl-cyanoacrylate for aneurysmal bone cysts? Int Orthop. 2017;41:1685–92. https://doi.org/10.1007/s00264-016-3364-3. Epub 2016 Dec 8View ArticlePubMedGoogle Scholar
  11. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;(286):241–6.Google Scholar
  12. Hou HY, Wu K, Wang CT, Chang SM, Lin WH, Yang RS. Treatment of unicameral bone cyst: a comparative study of selected techniques. J Bone Joint Surg Am. 2010;92:855–62. https://doi.org/10.2106/JBJS.I.00607.View ArticlePubMedGoogle Scholar
  13. Neer CS 2nd, Francis KC, Marcove RC, Terz J, Carbonara PN. Treatment of unicameral bone cyst. A follow-up study of one hundred seventy-five cases. J Bone Joint Surg Am. 1966;48:731–45.View ArticlePubMedGoogle Scholar
  14. Jaffe HL, Lichtenstein L. Solitary unicameral bone cyst with emphasis on the roentgen picture, the pathologic appearance and the pathogenesis. Arch Surg. 1942;44:1004–25. https://doi.org/10.1001/archsurg.1942.01210240043003.View ArticleGoogle Scholar
  15. Ozaki T, Hillmann A, Lindner N, Winkelmann W. Aneurysmal bone cysts in children. J Cancer Res Clin Oncol. 1996;122:767–9.View ArticlePubMedGoogle Scholar
  16. Peeters SP, Van der Geest IC, de Rooy JW, Veth RP, Schreuder HW. Aneurysmal bone cyst: the role of cryosurgery as local adjuvant treatment. J Surg Oncol. 2009;100:719–24. https://doi.org/10.1002/jso.21410.View ArticlePubMedGoogle Scholar
  17. Keçeci B, Küçük L, Isayev A, Sabah D. Effect of adjuvant therapies on recurrence in aneurysmal bone cysts. Acta Orthop Traumatol Turc. 2014;48:500–6. https://doi.org/10.3944/AOTT.2014.14.0020.View ArticlePubMedGoogle Scholar
  18. Choi Y, Kwak JM, Chung SH, Jung GH, Kim JD. Tumor treated by endoscopy. Clin Orthop Surg. 2014;6:72–9. https://doi.org/10.4055/cios.2014.6.1.72.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Dietz JF, Kachar SM, Nagle DJ. Endoscopically assisted excision of digital enchondroma. Arthroscopy. 2007;23:678.e1–4.View ArticleGoogle Scholar
  20. Sekiya I, Matsui N, Otsuka T, Kobayashi M, Tsuchiya D. The treatment of enchondromas in the hand by endoscopic curettage without bone grafting. J Hand Surg Br. 1997;22:230–4.View ArticlePubMedGoogle Scholar
  21. Okamoto H, Kobayashi M, Sekiya I, Shinzi M, Endo K, Otsuka T. Surgery for enchondroma on the fingers - endoscopic curettage. Central Jpn J Orthop Surg Traumatol. 2017;60:53–4. [in Japanese]Google Scholar
  22. Otsuka T, Kobayashi M, Yonezawa M, Kamiyama F, Matsushita Y, Matsui N. The treatment of enchondromas in the hand by endoscopic curettage without bone grafting. Arthroscopy. 2002;18:430–5.View ArticlePubMedGoogle Scholar
  23. Stricker SJ. Extraarticular endoscopic excision of femoral head chondroblastoma. J Pediatr Orthop. 1995;15:578–81.View ArticlePubMedGoogle Scholar
  24. Errani C, Traina F, Chehrassan M, Donati D, Faldini C. Minimally invasive technique for curettage of chondroblastoma using endoscopic technique. Eur Rev Med Pharmacol Sci. 2014;18:3394–8.PubMedGoogle Scholar
  25. Louahem D, Kouyoumdjian P, Ghanem I, Mazeau P, Perrochia H, L'kaissi M, Cottalorda J. Active aneurysmal bone cysts in children: possible evolution after biopsy. J Child Orthop. 2012;6:333–8. https://doi.org/10.1007/s11832-012-0424-0.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Tsagozis P, Brosjö O. Current strategies for the treatment of aneurysmal bone cysts. Orthop Rev (Pavia). 2015;7:6182. https://doi.org/10.4081/or.2015.6182.View ArticleGoogle Scholar
  27. Snyder BD, Hauser-Kara DA, Hipp JA, Zurakowski D, Hecht AC, Gebhardt MC. Predicting fracture through benign skeletal lesions with quantitative computed tomography. J Bone Joint Surg Am. 2006;88:55–70.PubMedGoogle Scholar
  28. Kaelin AJ, MacEwen GD. Unicameral bone cysts. Natural history and the risk of fracture. Int Orthop. 1989;13:275–82.View ArticlePubMedGoogle Scholar
  29. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989;249:256–64.Google Scholar
  30. Kapila R, Sharma R, Sohal YS, Singh D, Singh S. Primary epiphyseal aneurysmal bone cyst of distal ulna. J Orthop Case Rep. 2015;5:85–7. https://doi.org/10.13107/jocr.2250-0685.356.PubMedPubMed CentralView ArticleGoogle Scholar
  31. Gibbs CP Jr, Hefele MC, Peabody TD, Montag AG, Aithal V, Simon MA. Aneurysmal bone cyst of the extremities. Factors related to local recurrence after curettage with a high-speed burr. J Bone Joint Surg Am. 1999;81:1671–8.View ArticlePubMedGoogle Scholar
  32. Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL, Gebhardt MC, Rosenberg AE, Fletcher JA. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004;165:1773–80.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement